| Date Filed | Type | Description |
| 09/26/2023 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 122,480 shares
@ $0
Disposed/sold 10,398 shares
@ $0
Disposed/sold 212,903 options to buy
@ $0
Disposed/sold 23,968 options to buy
@ $121.29, valued at
$2.9M
Disposed/sold 275,436 options to buy
@ $25.03, valued at
$6.9M
Disposed/sold 146,824 options to buy
@ $36.71, valued at
$5.4M
Disposed/sold 51,818 options to buy
@ $11, valued at
$570k
Disposed/sold 99,950 options to buy
@ $22.57, valued at
$2.3M
Disposed/sold 124,600 options to buy
@ $24.75, valued at
$3.1M
Disposed/sold 57,250 options to buy
@ $55.73, valued at
$3.2M
Disposed/sold 28,625 options to buy
@ $55.73, valued at
$1.6M
|
|
| 07/10/2023 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 11,656 shares
@ $0
Granted 72,564 shares
@ $0
Granted 275,436 options to buy
@ $25.03, valued at
$6.9M
|
|
| 01/04/2023 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 47,025 shares
@ $0
Granted 190,950 options to buy
@ $36.71, valued at
$7M
|
|
| 01/06/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2020 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 16,687 shares
@ $175.0639, valued at
$2.9M
Sold 64,970 shares
@ $175.0001, valued at
$11.4M
|
|
| 01/06/2020 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options to buy
@ $207.2, valued at
$8.3M
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Gifted 12,500 shares
@ $0
Gifted 12,500 shares
@ $0
Gifted 7,000 shares
@ $0
Sold 63,000 shares
@ $86.605, valued at
$5.5M
|
|
| 01/03/2019 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 114,500 options to buy
@ $55.73, valued at
$6.4M
|
|
| 07/31/2018 |
SC 13D/A
| Huff James Warren reports a 4.5% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 12/13/2017 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Exercised 10,000 options to buy
@ $11, valued at
$110k
|
|
| 12/07/2017 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 249,200 options to buy
@ $24.75, valued at
$6.2M
|
|
| 08/01/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/06/2016 |
SC 13D
| Huff James Warren reports a 10.9% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 06/02/2016 |
4
| Huff James Warren (See Remarks) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 62,657 shares
@ $0
Bought 114,000 shares
@ $11, valued at
$1.3M
Converted 3,166 shares
@ $0
Converted 62,567 options to buy
@ $0
Converted 3,166 options to buy
@ $0 |
|
| 05/31/2016 |
3/A
| Huff James Warren (See Remarks) has filed a Form 3/A on REATA PHARMACEUTICALS INC |
| 05/26/2016 |
4
| Huff James Warren (See Remarks) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 113,636 options to buy
@ $11, valued at
$1.2M
|
|
| 05/25/2016 |
3
| Huff James Warren (See Remarks) has filed a Form 3 on REATA PHARMACEUTICALS INC |